Margaret Sallberg Chen
Overview
Explore the profile of Margaret Sallberg Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
663
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lu L, Yan L, Sohrabi A, Lindahl K, Cederberg S, Wang R, et al.
J Dent Sci
. 2025 Jan;
19(Suppl 1):S17-S25.
PMID: 39807439
Background/purpose: Dysbiosis of oral microbiota has been reported in late stage of chronic hepatitis B (CHB) infection with cirrhosis. CHB is characterized by the constant virus-induced liver injury which may...
2.
Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, et al.
EBioMedicine
. 2024 Oct;
109:105385.
PMID: 39395230
Background: Immunocompromised patients with primary and secondary immunodeficiencies have shown impaired responses to SARS-CoV-2 mRNA vaccines, necessitating recommendations for additional booster doses. However, longitudinal data reflecting the real-world impact of...
3.
Narayanan A, Kieri O, Vesterbacka J, Manoharan L, Chen P, Ghorbani M, et al.
Sci Rep
. 2024 Aug;
14(1):17820.
PMID: 39090139
The gut and oral microbiome is altered in people living with HIV (PLWH). While antiretroviral treatment (ART) is pivotal in restoring immune function in PLWH, several studies have identified an...
4.
Bladh O, Aguilera K, Marking U, Kihlgren M, Greilert Norin N, Smed-Sorensen A, et al.
Front Immunol
. 2024 Apr;
15:1346749.
PMID: 38558811
Introduction: Several novel vaccine platforms aim at mucosal immunity in the respiratory tract to block SARS-CoV-2 transmission. Standardized methods for mucosal sample collection and quantification of mucosal antibodies are therefore...
5.
Muller T, Gao Y, Wu J, Ribeiro O, Chen P, Bergman P, et al.
Cell Host Microbe
. 2024 Jan;
32(2):156-161.e3.
PMID: 38211584
T cells are critical in mediating the early control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infection. However, it remains unknown whether memory T cells can effectively cross-recognize...
6.
Ray S, Narayanan A, Vesterbacka J, Blennow O, Chen P, Gao Y, et al.
NPJ Biofilms Microbiomes
. 2023 Dec;
9(1):104.
PMID: 38123600
Although mRNA SARS-CoV-2 vaccines are generally safe and effective, in certain immunocompromised individuals they can elicit poor immunogenic responses. Among these individuals, people living with HIV (PLWH) have poor immunogenicity...
7.
Andersson M, Wu J, Wullimann D, Gao Y, Aberg M, Muschiol S, et al.
J Hematol
. 2023 Sep;
12(4):170-175.
PMID: 37692865
Background: Patients with chronic lymphocytic leukemia (CLL) are vulnerable to coronavirus disease 2019 (COVID-19) and are at risk of inferior response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination,...
8.
Ingelman-Sundberg H, Blixt L, Wullimann D, Wu J, Gao Y, Healy K, et al.
Haematologica
. 2023 Aug;
109(2):646-651.
PMID: 37646668
No abstract available.
9.
Al-Manei K, Sobkowiak M, Nagadia R, Heymann R, Sallberg Chen M, Ozenci V
Oral Oncol
. 2023 Aug;
146:106556.
PMID: 37611433
Objectives: Head and neck cancer (HNC) impairs patient immunity and increases susceptibility to oral fungal infections (OFIs). Effectively treating such infections requires accurate identification of the causative pathogens. This study...
10.
Chen P, Bergman P, Blennow O, Hansson L, Mielke S, Nowak P, et al.
EBioMedicine
. 2023 Jul;
94:104700.
PMID: 37453361
Background: Immunocompromised patients have varying responses to SARS-CoV-2 mRNA vaccination. However, there is limited information available from prospective clinical trial cohorts with respect to long-term immunogenicity-related responses in these patient...